Xu N - Search Results

1

A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer.

Jiang H, Qian J, Zhao P, Zhang X, Zheng Y, Mao C, Zheng Y, Chen L, Wang Y, Mou H, Fang W, Teng L, Xu N. Jiang H, et al. Among authors: xu n. Cancer Chemother Pharmacol. 2015 Jul;76(1):197-203. doi: 10.1007/s00280-015-2782-z. Epub 2015 May 27. Cancer Chemother Pharmacol. 2015. PMID: 26013324 Clinical Trial.

2

The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer.

Wang L, Wu X, Huang M, Cai J, Xu N, Liu J. Wang L, et al. Among authors: xu n. Cancer Chemother Pharmacol. 2007 Jul;60(2):211-8. doi: 10.1007/s00280-006-0363-x. Epub 2006 Nov 24. Cancer Chemother Pharmacol. 2007. PMID: 17124596 Clinical Trial.

3

Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer.

Zhang CX, Huang S, Xu N, Fang JW, Shen P, Bao YH, Mou BH, Shi MG, Zhong XL, Xiong PJ. Zhang CX, et al. Among authors: xu n. Anticancer Drugs. 2007 Jun;18(5):581-6. doi: 10.1097/CAD.0b013e3280146296. Anticancer Drugs. 2007. PMID: 17414627 Clinical Trial.

4

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.

Wang LR, Huang MZ, Zhang GB, Xu N, Wu XH. Wang LR, et al. Among authors: xu n. Cancer Chemother Pharmacol. 2007 Sep;60(4):601-7. doi: 10.1007/s00280-007-0504-x. Epub 2007 Jun 5. Cancer Chemother Pharmacol. 2007. PMID: 17549479 Clinical Trial.

5

A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium.

Xu N, Zhang XC, Xiong JP, Fang WJ, Yu LF, Qian J, Zhang L. Xu N, et al. BMC Cancer. 2007 Jun 9;7:98. doi: 10.1186/1471-2407-7-98. BMC Cancer. 2007. PMID: 17559681 Free PMC article. Clinical Trial.

6

A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.

Xu N, Fang WJ, Zhang XC, Yu LF, Bao HY, Shi GM, Huang S, Shen P. Xu N, et al. Cancer Invest. 2007;25(7):599-605. doi: 10.1080/07357900701470739. Cancer Invest. 2007. PMID: 17882631 Clinical Trial.

7

Bone marrow metastasis of desmoplastic small round cell tumor.

Deng J, Xu N, Shen P, Wang Z, Zhang X, Lou H, Shi G. Deng J, et al. Among authors: xu n. Tumori. 2007 Sep-Oct;93(5):511-3. doi: 10.1177/030089160709300520. Tumori. 2007. PMID: 18038889

8

Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin.

Bao HY, Fang WJ, Zhang XC, Shi GM, Huang S, Yu LF, Chen J, Mou HB, Deng J, Shen P, Xu N. Bao HY, et al. Among authors: xu n. Cancer Chemother Pharmacol. 2011 Jan;67(1):147-52. doi: 10.1007/s00280-010-1301-5. Epub 2010 Mar 11. Cancer Chemother Pharmacol. 2011. PMID: 20221830 Clinical Trial.

9

Inferior vena cava thrombus in renal primitive neuroectodermal tumor is not rare.

Xu N, Zheng Y, Zhang X, Gao Q, Peng Z. Xu N, et al. J Natl Med Assoc. 2010 Jul;102(7):654-6. J Natl Med Assoc. 2010. PMID: 20690331 No abstract available.

10

Primary primitive neuroectodermal tumor of the urinary bladder: a case report and literature review.

Zheng Y, Tan F, Wang L, Xu N, Mou H. Zheng Y, et al. Among authors: xu n. Med Oncol. 2011 Dec;28 Suppl 1:S388-91. doi: 10.1007/s12032-010-9680-3. Epub 2010 Sep 18. Med Oncol. 2011. PMID: 20852971 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,990 results

Search Page

Filters